Vaxcyte

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vaxcyte and other ETFs, options, and stocks.

About PCVX

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology.

CEO

Grant E. Pickering

CEOGrant E. Pickering

Employees

Employees89

Headquarters

San Carlos, California

HeadquartersSan Carlos, California

Founded

2013

Founded2013

Employees

Employees89

PCVX Key Statistics

Market cap

1.47B

Market cap1.47B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

504.67K

Average volume504.67K

High today

$25.00

High today$25.00

Low today

$24.04

Low today$24.04

Open price

$24.75

Open price$24.75

Volume

240.55K

Volume240.55K

52 Week high

$29.73

52 Week high$29.73

52 Week low

$16.78

52 Week low$16.78

PCVX Earnings

-$0.80

-$0.53

-$0.27

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, After Hours

ActualExpected Nov 9, After Hours

Vaxcyte

Why Robinhood?

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. Show more

PCVX Key Statistics

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology.